Abstract
The in vivo recovery of factor VIII has been estimated on 84 occasions in 53 severely affected adolescent haemophiliacs. There was wide individual variation in recovery, which was not affected by differences in the administered dose. Recovery increased steadily with increasing surface area, and it was only over a surface area of 1.7 m2 that a recovery of 2% of factor VIII per unit per kg became the norm. It is suggested that the only safe assumption to make below that surface area in an in vivo recovery of 1.5%.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronstam A., Wasssef M., Choudhury D. P., Turk P. M., McLellan D. S. Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A. Lancet. 1980 Jan 26;1(8161):169–171. doi: 10.1016/s0140-6736(80)90659-5. [DOI] [PubMed] [Google Scholar]
- Lurie A. The laboratory assessment of the efficacy of antihaemophilic therapy. S Afr Med J. 1972 Jun 17;46(25):844–844. [PubMed] [Google Scholar]
- Rizza C. R. The management of haemophilia. Practitioner. 1970 Jun;204(224):763–772. [PubMed] [Google Scholar]
- Woodruff P. W. My student elective. Problems in Peru. Br Med J. 1980 Jan 5;280(6206):32–33. doi: 10.1136/bmj.280.6206.32. [DOI] [PMC free article] [PubMed] [Google Scholar]